Your browser doesn't support javascript.
loading
Preoperative plasma level of endoglin as a predictor for disease outcomes after radical cystectomy for nonmetastatic urothelial carcinoma of the bladder.
Laukhtina, Ekaterina; Schuettfort, Victor M; D'Andrea, David; Pradere, Benjamin; Mori, Keiichiro; Quhal, Fahad; Sari Motlagh, Reza; Mostafaei, Hadi; Katayama, Satoshi; Grossmann, Nico С; Rajwa, Pawel; Zeinler, Flora; Abufaraj, Mohammad; Moschini, Marco; Zimmermann, Kristin; Karakiewicz, Pierre I; Fajkovic, Harun; Scherr, Douglas; Compérat, Eva; Nyirady, Peter; Rink, Michael; Enikeev, Dmitry; Shariat, Shahrokh F.
Afiliación
  • Laukhtina E; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Schuettfort VM; Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia.
  • D'Andrea D; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Pradere B; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Mori K; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Quhal F; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Sari Motlagh R; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Mostafaei H; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.
  • Katayama S; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Grossmann NС; Department of Urology, King Fahad Specialist Hospital, Dammam, Saudi Arabia.
  • Rajwa P; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Zeinler F; Men's Health and Reproductive Health Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Abufaraj M; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Moschini M; Research Center for Evidence Based Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Zimmermann K; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Karakiewicz PI; Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
  • Fajkovic H; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Scherr D; Department of Urology, University Hospital Zurich, Zurich, Switzerland.
  • Compérat E; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Nyirady P; Department of Urology, Medical University of Silesia, Zabrze, Poland.
  • Rink M; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Enikeev D; Department of Special Surgery, Division of Urology, Jordan University Hospital, The University of Jordan, Amman, Jordan.
  • Shariat SF; Department of Urology, Luzerner Kantonsspital, Lucerne, Switzerland.
Mol Carcinog ; 61(1): 5-18, 2022 01.
Article en En | MEDLINE | ID: mdl-34587660
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Vejiga Urinaria / Carcinoma de Células Transicionales / Biomarcadores de Tumor / Endoglina Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Mol Carcinog Asunto de la revista: BIOLOGIA MOLECULAR / NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Austria
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Vejiga Urinaria / Carcinoma de Células Transicionales / Biomarcadores de Tumor / Endoglina Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Mol Carcinog Asunto de la revista: BIOLOGIA MOLECULAR / NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Austria